Comparison of Vitreous Levels of Acular LS 0.04%, Xibrom 0.09%, and Nevanac 0.1%
NCT00377546 · Status: COMPLETED · Phase: PHASE4 · Type: INTERVENTIONAL
Last updated 2008-09-25
Summary
To compare the penetration of three different NSAIDs.
Conditions
- Vitrectomy
Interventions
- DRUG
-
Nepafenac
- DRUG
-
Ketorolac LS, Bromfenac
Sponsors & Collaborators
-
Innovative Medical
lead INDUSTRY
Principal Investigators
-
Jeffrey Heier, MD · Ophthalmic Consultants of Boston
Study Design
- Allocation
- RANDOMIZED
- Masking
- DOUBLE
- Model
- PARALLEL
Eligibility
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
Countries
- United States
Study Locations
More Related Trials
-
Acular LS vs. Nevanac in Post op Inflammation Following Cataract Surgery
NCT00348582 ·Status: COMPLETED ·Phase: PHASE4
-
Comparison of Acular LS Versus Nevanac for Pain Control in Eyes Undergoing PRK
NCT00347204 ·Status: COMPLETED ·Phase: PHASE4
-
Evaluation of Comfort With Xibrom (Bromfenac Ophthalmic Solution)0.09% and Nevanac (Nepafenac Ophthalmic Suspension) 0.1% Following Selective Laser Trabeculoplasty (SLT)
NCT00828477 ·Status: COMPLETED ·Phase: PHASE4
-
Prolensa (Bromfenac) 0.07% QD vs. Ilevro (Nepafenac) 0.3% QD for Treatment of Ocular Inflammation Post Cataract Surgery
NCT01847638 ·Status: COMPLETED ·Phase: NA
-
A Comparison of Post Phacoemulsification Aqueous Flare in Patients Using Ketorolac 0.45% 2 Times Daily (BID) and Bromfenac 0.09% 2 Times Daily (BID)
NCT01023724 ·Status: COMPLETED ·Phase: PHASE4
-
NSAIDs and PGE2 Levels in Vitrectomy Patients
NCT02361645 ·Status: COMPLETED ·Phase: PHASE3
-
Nepafenac Opthalmic Suspension 0.1% Compared to Acular LS for Treatment of Inflammation After Cataract Surgery
NCT00333255 ·Status: COMPLETED ·Phase: PHASE3
-
Nepafenac Versus Ketorolac Eye Drops in Prevention of Intraoperative Miosis During Cataract Surgery
NCT03851172 ·Status: UNKNOWN ·Phase: PHASE2
-
Ketorolac vs. Steroid in the Prevention of CME
NCT00348244 ·Status: COMPLETED ·Phase: PHASE4
-
Bromday Versus Nevanac Eye Drops to Control Pain Following Photorefractive Keratectomy
NCT01475877 ·Status: COMPLETED
-
Comparison of Pain Sensation During Single Use of Two Topical Non-Steroidal Anti-Inflammatory Drugs (NSAIDs)
NCT00869219 ·Status: UNKNOWN ·Phase: PHASE4
-
Comparing Optical Coherence Tomography (OCT) and Visual Acuity Outcomes in Subjects Undergoing Cataract Surgery, Who Receive Xibrom Ophthalmic Solution and Standard Presurgical Care vs. Xibrom Ophthalmic Solution Plus Prednisolone Acetate 1% and Standard Presurgical Care
NCT00698724 ·Status: COMPLETED ·Phase: PHASE4
-
Determination of Optimum Duration of Treatment With Bromfenac (Xibrom) Eyedrops Following Cataract Surgery
NCT00758199 ·Status: COMPLETED ·Phase: PHASE4
-
Aqueous Humor Concentration of InSite Vision (ISV) 303 (Bromfenac in DuraSite) to Bromday Once Daily (QD) Prior to Cataract Surgery
NCT01387464 ·Status: COMPLETED ·Phase: PHASE2
-
Study Title: Clinical Outcomes of Prolensa (Bromfenac Ophthalmic Solution) 0.07% QD vs. Ilevro (Nepafenac Ophthalmic Suspension) 0.3% QD With Extra (Pulse) Dose on Day of Surgery for Treatment of Ocular Inflammation Associated With Cataract Surgery in a Randomized, Single Masked Clinical Trial
NCT03886779 ·Status: COMPLETED ·Phase: PHASE4
-
Tolerability and Toxicity of Topically Applied Nepafenac 0.3% vs Ketorolac 0.5%
NCT02752646 ·Status: COMPLETED ·Phase: NA
-
Efficacy and Safety of Bromfenac Ophthalmic Solution in Cataract Surgery
NCT00703781 ·Status: COMPLETED ·Phase: PHASE3
-
Nepafenac 0.1% Eye Drops, Suspension Compared to Ketorolac Trometamol 0.5% Eye Drops, Solution and Placebo
NCT00405730 ·Status: COMPLETED ·Phase: PHASE3
-
Effect of Prophylactic Ketorolac on CME After Cataract Surgery
NCT00335439 ·Status: COMPLETED ·Phase: NA
-
Efficacy Study of Bromfenac Ophthalmic Solution in Patients Undergoing Cataract Surgery
NCT00853970 ·Status: COMPLETED ·Phase: PHASE3
-
Comparison of the Efficacy of Nepafenac 0.1% and Nepafenac 0.3 % on Pain Associated With Intravitreal Injections
NCT03406689 ·Status: COMPLETED ·Phase: NA
-
Comparison of Acular LS With Lotemax to Prevent Inflammation After Cataract Surgery and Intraocular Lens Implantation
NCT00366691 ·Status: COMPLETED ·Phase: PHASE4
-
Clinical Outcomes of Bromday (Bromfenac Ophthalmic Solution) 0.09% QD vs. Nevanac (Nepafenac Ophthalmic Suspension) 0.1%
NCT01310127 ·Status: COMPLETED ·Phase: PHASE4
-
Efficacy and Safety of Bromfenac Ophthalmic Solution in Cataract Surgery
NCT00704418 ·Status: COMPLETED ·Phase: PHASE3
-
Ocular Tissue Levels of 1.5% Levofloxacin Ophthalmic Solution Compared to an Active Comparator
NCT00630019 ·Status: COMPLETED ·Phase: PHASE4